Nyhet -
Discovery Summit 2011- Attana AB attending!
The Discovery Summit 2011 is a unique forum taking place at the Majestic Barrière Hotel, Cannes, France, 21 - 23 March 2011. This exclusive meeting will bring together esteemed industry thought leaders and solution providers to a highly focused and interactive networking event. Keynote speakers include: Dr Lorenz Mayr, Executive Director, Unit Head Biology, Protease Platform, Novartis Pharma; Dr Torsten Hoffmann, Head Discovery Chemistry, F. Hoffmann-La Roche; Dr Theo Meert, Senior Director External Innovation Neurosciences, Johnson & Johnson. “Drug discovery scientists should focus on the biological relevance of their candidate molecules as soon as possible in their research, to ensure a high probability of success in later stages”, says Teodor Aastrup, Chief Executive Officer and Founder of Attana AB. How can drug discovery become more efficient? What are some of the scientific areas or technologies worth following? Teodor Aastrup discusses the role biologics can play in speeding up drug discovery and subsequent stages, in a recent interview with the Discovery Summit Press Team.
Attana AB has been a sponsor company at the Discovery Summit for the last four years. “What brings us back is a good mix of people generating valuable meetings and high class presentations”, says Teodor Aastrup.
marcus evans - a dominant force in the delivery of strategic information
The Discovery Summit is an exclusive, invitation only event.
For more information:
Daniela Trojakova
Marketing Manager
Tel: +357 22 849 380
Email: summitspr@marcusevanscy.com
Twitter: twitter.com/meSummitsPharma
LinkedIn: www.linkedin.com/pharmanetwork
Ämnen
- Vetenskap, teknik
Kategorier
- teodor aastrup
- biosensor
- attana cell 200
- attana a200
- biological relevance
- attana
- discovery summit